111 related articles for article (PubMed ID: 29179992)
1. Detection of a novel mutation conferring acyclovir resistance and consecutive treatment failure in an HIV-positive patient with recurrent HSV-2 infection.
Schleenvoigt BT; Pletz MW; Deinhardt-Emmer S; Sauerbrei A
J Glob Antimicrob Resist; 2018 Mar; 12():20. PubMed ID: 29179992
[No Abstract] [Full Text] [Related]
2. Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man.
Henao-Martínez AF; Weinberg A; Waldman WJ; Levi ME
J Clin Virol; 2012 Jul; 54(3):276-8. PubMed ID: 22465339
[TBL] [Abstract][Full Text] [Related]
3. Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.
Watson-Jones D; Wald A; Celum C; Lingappa J; Weiss HA; Changalucha J; Baisley K; Tanton C; Hayes RJ; Marshak JO; Gladden RG; Koelle DM
J Clin Microbiol; 2010 Oct; 48(10):3496-503. PubMed ID: 20702659
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Chibo D; Mijch A; Doherty R; Birch C
J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
Baeten JM; Lingappa J; Beck I; Frenkel LM; Pepper G; Celum C; Wald A; Fife KH; Were E; Mugo N; Sanchez J; Essex M; Makhema J; Kiarie J; Farquhar C; Corey L
J Infect Dis; 2011 Jan; 203(1):117-21. PubMed ID: 21148504
[TBL] [Abstract][Full Text] [Related]
6. Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV).
Arinze F; Shaver A; Raffanti S
Infection; 2017 Oct; 45(5):705-707. PubMed ID: 28508238
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient.
Pardeiro M; Cuenca-Estrella M; Fernández-Clúa MA; Santos-O'Connor F; Tabarés E; Gadea I
J Med Virol; 2004 May; 73(1):60-4. PubMed ID: 15042649
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G
J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707
[TBL] [Abstract][Full Text] [Related]
9. Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.
Kim HN; Wang J; Hughes J; Coombs R; Sanchez J; Reid S; Delany-Moretlwe S; Cowan F; Fuchs J; Eshleman SH; Khaki L; McMahon MA; Siliciano RF; Wald A; Celum C
J Infect Dis; 2010 Sep; 202(5):734-8. PubMed ID: 20649426
[TBL] [Abstract][Full Text] [Related]
10. Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy.
Daikoku T; Tannai H; Honda M; Onoe T; Matsuo K; Onoye Y; Nishizawa M; Kawana T; Okuda T; Hasegawa T; Shiraki K
J Dermatol Sci; 2016 Jun; 82(3):160-5. PubMed ID: 26917345
[TBL] [Abstract][Full Text] [Related]
11. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy.
Sbidian E; Battistella M; Legoff J; Lafaurie M; Bézier M; Agbalika F; Simon F; Bouscarat F; Cayuela JM; Carcelain G; Houhou N; Bagot M; Molina JM; Janier M; Bachelez H
Clin Infect Dis; 2013 Dec; 57(11):1648-55. PubMed ID: 24065320
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
13. Time to refocus on HSV interventions for HIV prevention?
Tanton C; Abu-Raddad LJ; Weiss HA
J Infect Dis; 2011 Dec; 204(12):1822-6. PubMed ID: 21998480
[No Abstract] [Full Text] [Related]
14. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.
McNicholl JM; Leelawiwat W; Whitehead S; Hanson DL; Evans-Strickfaden T; Cheng CY; Chonwattana W; Mueanpai F; Kittinunvorakoon C; Markowitz L; Dunne EF
Int J STD AIDS; 2017 Mar; 28(4):372-379. PubMed ID: 27179350
[TBL] [Abstract][Full Text] [Related]
15. Treatment of genital herpes infections in HIV-infected patients.
Foley E; Patel R
J HIV Ther; 2004 Feb; 9(1):14-8. PubMed ID: 15071425
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus: a new era?
Van de Perre P; Nagot N
Lancet; 2012 Feb; 379(9816):598-9. PubMed ID: 22226046
[No Abstract] [Full Text] [Related]
18. Recurrent antiviral-resistant genital herpes in an immunocompetent patient.
Kriesel JD; Spruance SL; Prichard M; Parker JN; Kern ER
J Infect Dis; 2005 Jul; 192(1):156-61. PubMed ID: 15942905
[TBL] [Abstract][Full Text] [Related]
19. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs.
McMahon MA; Siliciano JD; Kohli RM; Siliciano RF
AIDS; 2010 Jan; 24(2):319-23. PubMed ID: 20009920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]